Montair

Let me tell you about Montair. It’s not a new flashy biologic or some complex device. It’s montelukast sodium, a leukotriene receptor antagonist, and it’s been around for a good while now. But in my two decades of pulmonology and allergy practice, I’ve seen its role evolve from a “maybe” add-on to a fundamental, often first-line, controller for specific phenotypes of patients. It sits in this interesting space—it’s a pill for lung and nose inflammation, which patients love for the convenience, but its effectiveness is incredibly dependent on the underlying pathophysiology.